Arabic Arabic English English French French German German
dark

Korean Pharma’s Phase III COVID Trial Will Compare Candidate to AZ Vaccine

​The trial will enroll about 4,000 people worldwide to confirm the drug’s safety and immunogenicity profiles.  Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Medtech Incubators and Accelerators: Where Are the Hubs for Medical Device Innovation?

Next Post

Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows

Related Posts
Total
0
Share